Microfluidics for Studying Pharmacodynamics of Antibiotics

Ritika Mohan, Amit V. Desai, Chotitath Sanpitakseree, Paul J A Kenis

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Rising antibiotic resistance is a significant global health issue with incorrect prescription of antibiotics being one of the major causes. Determination of the minimum inhibitory concentration (MIC) of an antibiotic against pathogens is typically used to determine the appropriate antibiotic dosing regimen before prescription. The conventional methods to determine MIC, however, are tedious, low throughput, and require relatively large sample volumes. Furthermore, MIC is not an optimal parameter since the MIC reflects only an end-point estimate of the effect of an antibiotic on the bacteria without taking into account the time course of action, which in turn leads to unpredictable in vivo results. Microfluidic approaches may be able to address these issues by generating precise time-kill curves in an automated, rapid, and multiplexed fashion using small sample volumes. The ability to generate multiple, precise time-kill curves enables the use of pharmacokinetic and pharmacodynamic (PK/PD) modeling to provide superior metrics for evaluating the antibiotic efficacy and to improve the prediction of in vivo results. In this chapter, we review prior work on microfluidic platforms for antibiotic susceptibility testing (AST) as well as the utilization of microfluidics in combination with PK/PD modeling for AST.

Original languageEnglish (US)
Title of host publicationMicro- and Nanosystems for Biotechnology
PublisherWiley
Pages177-202
Number of pages26
ISBN (Electronic)9783527801312
ISBN (Print)9783527332816
DOIs
StatePublished - Apr 29 2016

Fingerprint

Pharmacodynamics
Microfluidics
Anti-Bacterial Agents
Microbial Sensitivity Tests
Pharmacokinetics
Prescriptions
Microbial Drug Resistance
Testing
Pathogens
Bacteria
Throughput
Health

Keywords

  • Antibiotic resistance
  • Antibiotic susceptibility testing (AST)
  • Pharmacokinetics-pharmacodynamics (PK/PD) modeling
  • Time-kill curves

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Mohan, R., Desai, A. V., Sanpitakseree, C., & Kenis, P. J. A. (2016). Microfluidics for Studying Pharmacodynamics of Antibiotics. In Micro- and Nanosystems for Biotechnology (pp. 177-202). Wiley. https://doi.org/10.1002/9783527801312.ch8

Microfluidics for Studying Pharmacodynamics of Antibiotics. / Mohan, Ritika; Desai, Amit V.; Sanpitakseree, Chotitath; Kenis, Paul J A.

Micro- and Nanosystems for Biotechnology. Wiley, 2016. p. 177-202.

Research output: Chapter in Book/Report/Conference proceedingChapter

Mohan, R, Desai, AV, Sanpitakseree, C & Kenis, PJA 2016, Microfluidics for Studying Pharmacodynamics of Antibiotics. in Micro- and Nanosystems for Biotechnology. Wiley, pp. 177-202. https://doi.org/10.1002/9783527801312.ch8
Mohan R, Desai AV, Sanpitakseree C, Kenis PJA. Microfluidics for Studying Pharmacodynamics of Antibiotics. In Micro- and Nanosystems for Biotechnology. Wiley. 2016. p. 177-202 https://doi.org/10.1002/9783527801312.ch8
Mohan, Ritika ; Desai, Amit V. ; Sanpitakseree, Chotitath ; Kenis, Paul J A. / Microfluidics for Studying Pharmacodynamics of Antibiotics. Micro- and Nanosystems for Biotechnology. Wiley, 2016. pp. 177-202
@inbook{3020423eb74348109ea471f7d596a719,
title = "Microfluidics for Studying Pharmacodynamics of Antibiotics",
abstract = "Rising antibiotic resistance is a significant global health issue with incorrect prescription of antibiotics being one of the major causes. Determination of the minimum inhibitory concentration (MIC) of an antibiotic against pathogens is typically used to determine the appropriate antibiotic dosing regimen before prescription. The conventional methods to determine MIC, however, are tedious, low throughput, and require relatively large sample volumes. Furthermore, MIC is not an optimal parameter since the MIC reflects only an end-point estimate of the effect of an antibiotic on the bacteria without taking into account the time course of action, which in turn leads to unpredictable in vivo results. Microfluidic approaches may be able to address these issues by generating precise time-kill curves in an automated, rapid, and multiplexed fashion using small sample volumes. The ability to generate multiple, precise time-kill curves enables the use of pharmacokinetic and pharmacodynamic (PK/PD) modeling to provide superior metrics for evaluating the antibiotic efficacy and to improve the prediction of in vivo results. In this chapter, we review prior work on microfluidic platforms for antibiotic susceptibility testing (AST) as well as the utilization of microfluidics in combination with PK/PD modeling for AST.",
keywords = "Antibiotic resistance, Antibiotic susceptibility testing (AST), Pharmacokinetics-pharmacodynamics (PK/PD) modeling, Time-kill curves",
author = "Ritika Mohan and Desai, {Amit V.} and Chotitath Sanpitakseree and Kenis, {Paul J A}",
year = "2016",
month = "4",
day = "29",
doi = "10.1002/9783527801312.ch8",
language = "English (US)",
isbn = "9783527332816",
pages = "177--202",
booktitle = "Micro- and Nanosystems for Biotechnology",
publisher = "Wiley",

}

TY - CHAP

T1 - Microfluidics for Studying Pharmacodynamics of Antibiotics

AU - Mohan, Ritika

AU - Desai, Amit V.

AU - Sanpitakseree, Chotitath

AU - Kenis, Paul J A

PY - 2016/4/29

Y1 - 2016/4/29

N2 - Rising antibiotic resistance is a significant global health issue with incorrect prescription of antibiotics being one of the major causes. Determination of the minimum inhibitory concentration (MIC) of an antibiotic against pathogens is typically used to determine the appropriate antibiotic dosing regimen before prescription. The conventional methods to determine MIC, however, are tedious, low throughput, and require relatively large sample volumes. Furthermore, MIC is not an optimal parameter since the MIC reflects only an end-point estimate of the effect of an antibiotic on the bacteria without taking into account the time course of action, which in turn leads to unpredictable in vivo results. Microfluidic approaches may be able to address these issues by generating precise time-kill curves in an automated, rapid, and multiplexed fashion using small sample volumes. The ability to generate multiple, precise time-kill curves enables the use of pharmacokinetic and pharmacodynamic (PK/PD) modeling to provide superior metrics for evaluating the antibiotic efficacy and to improve the prediction of in vivo results. In this chapter, we review prior work on microfluidic platforms for antibiotic susceptibility testing (AST) as well as the utilization of microfluidics in combination with PK/PD modeling for AST.

AB - Rising antibiotic resistance is a significant global health issue with incorrect prescription of antibiotics being one of the major causes. Determination of the minimum inhibitory concentration (MIC) of an antibiotic against pathogens is typically used to determine the appropriate antibiotic dosing regimen before prescription. The conventional methods to determine MIC, however, are tedious, low throughput, and require relatively large sample volumes. Furthermore, MIC is not an optimal parameter since the MIC reflects only an end-point estimate of the effect of an antibiotic on the bacteria without taking into account the time course of action, which in turn leads to unpredictable in vivo results. Microfluidic approaches may be able to address these issues by generating precise time-kill curves in an automated, rapid, and multiplexed fashion using small sample volumes. The ability to generate multiple, precise time-kill curves enables the use of pharmacokinetic and pharmacodynamic (PK/PD) modeling to provide superior metrics for evaluating the antibiotic efficacy and to improve the prediction of in vivo results. In this chapter, we review prior work on microfluidic platforms for antibiotic susceptibility testing (AST) as well as the utilization of microfluidics in combination with PK/PD modeling for AST.

KW - Antibiotic resistance

KW - Antibiotic susceptibility testing (AST)

KW - Pharmacokinetics-pharmacodynamics (PK/PD) modeling

KW - Time-kill curves

UR - http://www.scopus.com/inward/record.url?scp=85046402407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046402407&partnerID=8YFLogxK

U2 - 10.1002/9783527801312.ch8

DO - 10.1002/9783527801312.ch8

M3 - Chapter

AN - SCOPUS:85046402407

SN - 9783527332816

SP - 177

EP - 202

BT - Micro- and Nanosystems for Biotechnology

PB - Wiley

ER -